136 Results for "

ETA

" in MedChemExpress (MCE) Product Catalog:
Products (136)

136 Results for "ETA" in MCE Product Catalog:

  • Isoforms Recommended:
32
32 Publications Verification
Cat. No.: HY-A0013
CAS No.: 147536-97-8
Bosentan is a competitive and dual antagonist of endothelin-1 (ET) for the ETA and ETB receptors with Ki of 4.7 nM and 95 nM in human SMC, respectively.
loading...
    loading...
32
32 Publications Verification
Cat. No.: HY-A0013A
CAS No.: 157212-55-0
Bosentan hydrate is a competitive and dual antagonist of endothelin-1 (ET) for the ETA and ETB receptors with Ki of 4.7 nM and 95 nM in human SMC, respectively.
loading...
    loading...
22
22 Cited Publications
Cat. No.: HY-10343
CAS No.: 425637-18-9
Purity:  99.79%
Synonyms: AEB071
Target:  

MARCKS PKC

Research Areas:  

Inflammation/Immunology Cancer

Sotrastaurin (AEB071) is a potent and orally-active pan-PKC inhibitor, with Kis of 0.22 nM, 0.64 nM, 0.95 nM, 1.8 nM, 2.1 nM and 3.2 nM for PKCθ, PKCβ, PKCα, PKCη, PKCδ and PKCε, respectively .
loading...
    loading...
22
22 Cited Publications
Cat. No.: HY-18980
CAS No.: 82-08-6
Synonyms: Mallotoxin; NSC 56346; NSC 94525
Rottlerin, a natural product purified from Mallotus Philippinensis, is a specific PKC inhibitor, with IC50 values for PKCδ of 3-6 μM, PKCα,β,γ of 30-42 μM, PKCε,η,ζ of 80-100 μM. Rottlerin acts as a direct mitochondrial uncoupler, and stimulates autophagy by targeting a signaling cascade upstream of mTORC1. Rottlerin induces apoptosis via caspase 3 activation . Rottlerin inhibits HIV-1 integration and Rabies virus (RABV) infection .
loading...
    loading...
15
15 Cited Publications
Cat. No.: HY-15894A
CAS No.: 173326-37-9
Purity:  98.66%
BQ-788 is a potent, selective ETB receptor antagonist with IC50 of 1.2 nM for inhibition of ET-1 binding to human Girardi heart cells, poorly inhibiting the binding to ETA receptors in human neuroblastoma cell line SK-N-MC cells with IC50 of 1300 nM .
loading...
    loading...
14
14 Cited Publications
Cat. No.: HY-14184
CAS No.: 441798-33-0
Purity:  99.85%
Synonyms: ACT-064992
Macitentan (ACT-064992) is an orally active, non-peptide dual ETA and ETB (endothelin receptor) antagonist. Macitentan has the potential for idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH) .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-P0202
CAS No.: 117399-94-7
Synonyms: ET-1 (swine, human)
Endothelin 1 (swine, human) (ET-1) is a synthetic peptide with the sequence of human and swine Endothelin 1, which is a potent endogenous vasoconstrictor. Endothelin 1 acts through two types of receptors ETA and ETB .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-P0202A
CAS No.: 394693-38-0
Synonyms: ET-1 (swine, human) TFA
Target:  

Endothelin Receptor

Research Areas:  

Cardiovascular Disease

Endothelin 1 (swine, human) (ET-1) TFA is a synthetic peptide with the sequence of human and swine Endothelin 1, which is a potent endogenous vasoconstrictor. Endothelin 1 TFA acts through two types of receptors ETA and ETB .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-15403
CAS No.: 173937-91-2
Purity:  99.58%
Synonyms: ABT-627; (+)-A 127722; A-147627
Atrasentan (ABT-627) is an endothelin receptor antagonist with IC50 of 0.0551 nM for ETA .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-15403A
CAS No.: 195733-43-8
Purity:  99.82%
Synonyms: ABT-627 hydrochloride; (+)-A 127722 hydrochloride; A-147627 hydrochloride
Atrasentan hydrochloride (ABT-627 hydrochloride) is a selective endothelin A receptor antagonist with an IC50 of 0.0551 nM for ETA .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-P78358
Purity:  ≥ 95%, as determined by reducing SDS-PAGE or Bis-Tris PAGE.
Synonyms: Osteopontin; Bone sialoprotein 1; Nephropontin; SPP-1; BNSP; OPN; SPP1; Uropontin; BSP-1; ETA-1; BSPI
Species:  
Source:  
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-12378
CAS No.: 136553-81-6
Purity:  99.82%
Target:  

Endothelin Receptor

Research Areas:  

Cardiovascular Disease

BQ-123 is a potent and selective endothelin A (ETA) receptor antagonist with an IC50 of 7.3 nM and a Ki of 25 nM. BQ-123 inhibits endothelin-1-mediated proliferation of human pulmonary artery smooth muscle cells and lowers blood pressure in different rat models of hypertension .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-109041
CAS No.: 1008510-37-9
Purity:  ≥98.0%
Synonyms: AKB-9778
Target:  

Phosphatase Tie

Research Areas:  

Inflammation/Immunology

Razuprotafib (AKB-9778) is a potent and selective inhibitor of the catalytic activity of VE-PTP (vascular endothelial protein tyrosine phosphatase) with an IC50of 17 pM. Razuprotafib promotes TIE2 activation, enhances ANG1-induced TIE2 activation, and stimulates phosphorylation of signaling molecules in the TIE2 pathway, including AKT, eNOS, and ERK. Razuprotafib inhibits the structurally related phosphatase PTP1B with an IC50 of 780 nM. Razuprotafib shows excellent selectivity for VE-PTP versus a variety of phosphatases, with the exception of HPTPη (IC50=36 pM) and HPTPγ (100 pM) .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-15895
CAS No.: 1103522-45-7
Purity:  99.98%
Synonyms: ACT-132577
Target:  

Endothelin Receptor

Aprocitentan (ACT-132577) is the major and pharmacologically active metabolite of Macitentan. Aprocitentan is an orally active dual ETA/ETB antagonist with IC50s of 3.4 nM and 987 nM, and pA2 valus of 6.7 and 5.5, respectively. Aprocitentan is an antihypertensive agent .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P71786
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: Spp1; ETA-1; Op; Spp-1; Osteopontin; 2AR; Minopontin; Secreted phosphoprotein 1; SPP-1
Species:  
Source:  
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-12307
CAS No.: 90365-57-4
Purity:  98.42%
Synonyms: Indolactam V
Target:  

PKC

Research Areas:  

Cancer

(-)-Indolactam V is a PKC activator, with Kis of 3.36 nM, 1.03 μM for η-CRD2 (PKCη surrogate peptide), γ-CRD2 (PKCγ surrogate peptide), and Kds of 5.5 nM (η-C1B), 7.7 nM (ε-C1B), 8.3 nM (δ-C1B), 18.9 nM (β-C1A-long), 20.8 nM (α-C1A-long), 137 nM (β-C1B), 138 nM (γ-C1A), 213 nM (γ-C1B), and has antitumor activity.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-146302
CAS No.: 2770842-10-7
Purity:  99.00%
Research Areas:  

Cancer

14-3-3η Protein inhibitor 1 (Compound C11) is a 14-3-3η protein inhibitor with a KD of 35 µM. 14-3-3η Protein inhibitor 1 shows inhibitory activities against several typical human liver cancer cell lines. 14-3-3η Protein inhibitor 1 induces cell apoptosis and G1-S cell cycle arrest with good metabolic stability .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-120295
CAS No.: 195529-54-5
Purity:  99.51%
A-192621, a chemical probe, is a potent, nonpeptide, orally active and selective endothelin B (ETB) receptor antagonist with an IC50 of 4.5 nM and a Ki of 8.8 nM. The selectivity of A-192621 is 636-fold higher than ETA (IC50 of 4280 nM and Ki of 5600 nM). A-192621 promotes apoptosis in PASMCs. A-192621 alos causes elevation of arterial blood pressure and an elevation in the plasma ET-1 level .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-11103
CAS No.: 210421-74-2
Purity:  98.83%
Synonyms: IPI 1040 sodium; TBC11251 sodium
Sitaxsentan sodium (IPI 1040 sodium; TBC11251 sodium) is a potent, selective and orally active endothelin A receptor (ETA) antagonist with an IC50 of 1.4 nM and a Ki of 0.43 nM. Sitaxsentan sodium exhibits an IC50 for the ETB receptor of as high as 9800 nM. Sitaxsentan sodium is metabolized by CYP2C9 and CYP3A4, normalizes shunt-induced endothelial abnormalities, restores BMPR signaling, and suppresses pulmonary vascular remodeling and hemodynamic deterioration. Sitaxsentan sodium can be applied in the research of pulmonary arterial hypertension and portopulmonary hypertension .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-76520
CAS No.: 184036-34-8
Synonyms: IPI 1040; TBC-11251
Sitaxsentan (IPI 1040 sodium; TBC11251 sodium) is a potent, selective and orally active endothelin A receptor (ETA) antagonist with an IC50 of 1.4 nM and a Ki of 0.43 nM. Sitaxsentan exhibits an IC50 for the ETB receptor of as high as 9800 nM. Sitaxsentan is metabolized by CYP2C9 and CYP3A4, normalizes shunt-induced endothelial abnormalities, restores BMPR signaling, and suppresses pulmonary vascular remodeling and hemodynamic deterioration. Sitaxsentan can be applied in the research of pulmonary arterial hypertension and portopulmonary hypertension .
loading...
    loading...